Russian Serialization: SEA Vision and OBL Pharm collaborate with CRPT for crypto-box connection
Preparing for serialization: why you need to start now
Serialization is one of the biggest issues facing the pharmaceutical industry today, and with upcoming deadlines in the U.S., and the EU, it should be a priority for all drug manufacturers. However, new industry research we’ve conducted has revealed that more than one-third of companies are not currently preparing for serialization global requirements.
Serialization is a task that cannot be completed over night, entire company-wide processes and systems need to be adapted in order to meet the new requirements.
Failing to comply with the new regulations can have a detrimental effect on the performance of your business, from costly downtime to loss of business in key markets. But why are some companies failing to act? Our research identified that a lack of internal resource is a contributing factor, while several industry professionals believe it is too early to begin preparations.
In a piece for European Pharmaceutical Manufacturer, Carlos Machado, serialization director at SEA Vision U.S., explores some of the challenges companies are facing when preparing for serialization and outlines some steps to success for those that are yet to make a start.
Companies need to recognize that implementing a serialization solution is a long-term project which requires existing processes and systems to be updated in time for regulatory deadlines and continually adapted to meet future requirements. Starting early is the key to success.
You can read more about how to prepare for serialization in European Pharmaceutical Manufacturer here.
Related Post
